Skip to content

KMW-1-02

Phase III study of KMW-1 in hospitalized patients with Deep Partial Thickness and Full Thickness thermal burns

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080224058
Enrollment
36
Registered
2018-09-17
Start date
2018-12-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Partial Thickness (DPT) and Full Thickness (FT) thermal burns

Interventions

investigational material(s) Generic name etc : KMW-1 INN of investigational material : - Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational materi

Sponsors

KAKEN PHARMACEUTICAL CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Hospitalized patients (all ages) Patient total burns area 3% or more DPT and / or FT Patient total burns area should be 30% or less TBSA; Superficial Partial Thickness (SPT), DPT and/or FT in depth

Exclusion criteria

Exclusion criteria: Patients with electrical or chemical burns

Design outcomes

Primary

MeasureTime frame
efficacy Incidence of complete eschar removal

Secondary

MeasureTime frame
safety efficacy % wound area eschar removed Time to achieve complete eschar removal

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026